Activation of the IKK2-NFκB pathway in VSMCs inhibits calcified vascular stiffness in CKD by reducing the secretion of calcifying extracellular vesicles. https://www.biorxiv.org/content/10.1101/2023.07.11.548621v1?med=mas
Activation of the IKK2-NFκB pathway in VSMCs inhibits calcified vascular stiffness in CKD by reducing the secretion of calcifying extracellular vesicles. https://www.biorxiv.org/content/10.1101/2023.07.11.548621v1?med=mas